loading
Olema Pharmaceuticals Inc stock is traded at $8.28, with a volume of 350.46K. It is down -5.05% in the last 24 hours and down -33.39% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$8.72
Open:
$8.71
24h Volume:
350.46K
Relative Volume:
0.77
Market Cap:
$474.43M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-3.4357
EPS:
-2.41
Net Cash Flow:
$-83.73M
1W Performance:
-27.87%
1M Performance:
-33.39%
6M Performance:
-13.03%
1Y Performance:
-48.09%
1-Day Range:
Value
$8.12
$8.79
1-Week Range:
Value
$8.12
$12.26
52-Week Range:
Value
$8.12
$16.77

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
Name
Olema Pharmaceuticals Inc
Name
Phone
(415) 651-3316
Name
Address
780 BRANNAN STREET, SAN FRANCISCO
Name
Employee
88
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
OLMA's Discussions on Twitter

Compare OLMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
OLMA 8.28 474.43M 0 -96.66M -83.73M -2.41
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-30-24 Initiated Citigroup Buy
Jul-21-23 Initiated Oppenheimer Outperform
May-05-23 Initiated CapitalOne Overweight
Feb-22-23 Initiated Credit Suisse Outperform
Jul-06-22 Resumed Canaccord Genuity Buy
Jun-09-22 Upgrade H.C. Wainwright Neutral → Buy
Feb-28-22 Initiated H.C. Wainwright Neutral
Dec-07-21 Resumed Cowen Outperform
Dec-14-20 Initiated Canaccord Genuity Buy
Dec-14-20 Initiated Cowen Outperform
Dec-14-20 Initiated JP Morgan Overweight
Dec-14-20 Initiated Jefferies Buy
View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

pulisher
03:38 AM

Victory Capital Management Inc. Has $10.17 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

03:38 AM
pulisher
Nov 18, 2024

Olema Pharmaceuticals stock hits 52-week low at $8.51 - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Olema Pharmaceuticals stock hits 52-week low at $8.51 By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

What is Lifesci Capital’s Estimate for OLMA FY2025 Earnings? - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

Equities Analysts Issue Forecasts for OLMA FY2024 Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

What is Lifesci Capital's Forecast for OLMA FY2025 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

What is HC Wainwright's Estimate for OLMA FY2024 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 12, 2024
pulisher
Nov 06, 2024

OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Olema Oncology to Present at Three Major Healthcare Investor Conferences | OLMA Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 04, 2024

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 04, 2024
pulisher
Nov 02, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Recommendation of “Buy” by Brokerages - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) PT at $27.00 - MarketBeat

Nov 02, 2024
pulisher
Oct 31, 2024

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation - Yahoo Finance

Oct 31, 2024
pulisher
Oct 26, 2024

Possible Bearish Signals With Olema Pharmaceuticals Insiders Disposing Stock - Simply Wall St

Oct 26, 2024
pulisher
Oct 25, 2024

SG Americas Securities LLC Acquires Shares of 13,056 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Oct 25, 2024
pulisher
Oct 24, 2024

Olema Pharmaceuticals (NASDAQ:OLMA) Earns Buy Rating from HC Wainwright - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Olema Pharmaceuticals maintains Buy rating from H.C. Wainwright By Investing.com - Investing.com UK

Oct 24, 2024
pulisher
Oct 24, 2024

Olema stock a buy as Goldman highlights promising preclinical data for KAT6 inhibitor - Investing.com UK

Oct 24, 2024
pulisher
Oct 23, 2024

Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024 - The Manila Times

Oct 23, 2024
pulisher
Oct 10, 2024

Insider Selling: Paradigm Biocapital Advisors L, Olema Pharmaceuticals Inc [OLMA] 10% Owner divested 2,400,000 shares – Knox Daily - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Closing Bell Recap: Olema Pharmaceuticals Inc (OLMA) Ends at 11.26, Reflecting a -1.23 Downturn - The Dwinnex

Oct 10, 2024
pulisher
Oct 10, 2024

Can you still get a good price for Olema Pharmaceuticals Inc (OLMA) Shares at this point? - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

Renaissance Technologies LLC Buys Shares of 53,200 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Point72 Asset Management L.P. Purchases New Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Aurigene Oncology, Olema Pharmaceuticals identify KAT6A inhibitors - BioWorld Online

Oct 08, 2024
pulisher
Oct 08, 2024

Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat

Oct 08, 2024
pulisher
Oct 05, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Dimensional Fund Advisors LP - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

OLMA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

Oct 04, 2024
pulisher
Oct 04, 2024

OLMA underperforms with a -4.07 decrease in share price - US Post News

Oct 04, 2024
pulisher
Oct 04, 2024

74,657 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Acquired by Dana Investment Advisors Inc. - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

olema pharmaceuticals, inc. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Oct 02, 2024

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 3.8% - MarketBeat

Oct 02, 2024
pulisher
Oct 02, 2024

Keeping an Eye on Olema Pharmaceuticals Inc (OLMA) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Insider’s View: Deciphering Olema Pharmaceuticals Inc (OLMA)’s Financial Health Through Ratios - The Dwinnex

Oct 02, 2024
pulisher
Oct 02, 2024

Long Term Trading Analysis for (OLMA) - Stock Traders Daily

Oct 02, 2024
pulisher
Oct 01, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Marshall Wace LLP - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Ensign Peak Advisors Inc Acquires 850 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Oct 01, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Purchases Shares of 275,000 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Invests $2.98 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Rhumbline Advisers Buys 17,953 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Logos Global Management LP - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Purchases New Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Examining the Potential Price Growth of Olema Pharmaceuticals Inc (OLMA) - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 6.3% - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Taking the lead: Olema Pharmaceuticals Inc (OLMA) - SETE News

Sep 20, 2024
pulisher
Sep 19, 2024

A Tale of Resilience: Olema Pharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle

Sep 19, 2024

Olema Pharmaceuticals Inc Stock (OLMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):